Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Renovorx Inc (RNXT)

Renovorx Inc (RNXT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
RenovoRx Initiates Patient Enrollment at SCRI Oncology Partners for Ongoing Pivotal Phase III TIGeR-PaC Clinical Trial in Locally Advanced Pancreatic Cancer GlobeNewswire - Wed Dec 11, 7:00AM CST

RNXT : 1.2500 (+8.70%)
RenovoRx CEO to Host Investor Fireside Chat on Tuesday, December 17th at 4:30 p.m. ET GlobeNewswire - Tue Dec 10, 7:00AM CST

RNXT : 1.2500 (+8.70%)
RenovoRx Secures Initial Purchase Orders for RenovoCath as Nationwide Demand Grows Quiver Quantitative, Inc. - Thu Dec 5, 5:20PM CST

RenovoRx reports initial purchase orders for RenovoCath, targeting a multi-million dollar oncology market, with Richard Stark as commercial advisor.Quiver AI SummaryRenovoRx, Inc. has announced a significant...

RNXT : 1.2500 (+8.70%)
RenovoRx Receives First Purchase Orders for its FDA-Cleared RenovoCath® Delivery System GlobeNewswire - Thu Dec 5, 7:00AM CST

RNXT : 1.2500 (+8.70%)
RenovoRx Expands TIGeR-PaC Study with Northwell Health Cancer Institute to Evaluate Innovative Treatment for Locally Advanced Pancreatic Cancer Quiver Quantitative, Inc. - Wed Nov 20, 5:52PM CST

Northwell Health Cancer Institute joins TIGeR-PaC study evaluating TAMP therapy for advanced pancreatic cancer. Full enrollment targeted by mid-2025.Quiver AI SummaryRenovoRx, Inc. has announced that the...

RNXT : 1.2500 (+8.70%)
Northwell Health Cancer Institute Launches Patient Enrollment in RenovoRx’s Ongoing Pivotal Phase III TIGeR-PaC Clinical Trial GlobeNewswire - Wed Nov 20, 7:45AM CST

RNXT : 1.2500 (+8.70%)
RenovoRx Reports Third Quarter 2024 Financial Results and Operational Highlights GlobeNewswire - Thu Nov 14, 7:00AM CST

RNXT : 1.2500 (+8.70%)
RenovoRx Sponsors Pancreatic Cancer Action Network’s PurpleStride® Event Business Wire - Mon May 1, 2023

RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a biopharmaceutical company focused on the localized treatment of solid tumors, announced it joined Pancreatic Cancer Action Network...

RNXT : 1.2500 (+8.70%)
RenovoRx to Participate in the Aegis Capital Virtual Conference on May 3, 2023 Business Wire - Fri Apr 28, 2023

RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a biopharmaceutical company focused on the localized treatment of solid tumors, announced that Shaun Bagai, CEO of RenovoRx, will present...

RNXT : 1.2500 (+8.70%)
RenovoRx Appoints Former Chief Medical Officer of Schering-Plough, Robert J. Spiegel, MD, FACP, to Board of Directors Business Wire - Thu Apr 27, 2023

RenovoRx, Inc . (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a biopharmaceutical company focused on targeted drug-delivery with an initial application in locally advanced pancreatic cancer (LAPC),...

RNXT : 1.2500 (+8.70%)

Barchart Exclusives

Oracle Stock Is Off Its Highs and Could Be Cheap Here Barchart - 29 minutes ago
Oracle Corp. produced higher revenue in Q2 but lower free cash flow and FCF margins. However, ORCL stock is now off its highs and could be undervalued here. Shorting out-of-the-money puts is one way to play it. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot